Akebia Therapeutics (AKBA) Property, Plant & Equipment (Net) (2013 - 2026)
Akebia Therapeutics (AKBA) Property, Plant & Equipment (Net) (2013 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 2.55 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.93 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.76 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 13.44 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.93 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 2.44 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 90.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.41 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.96 Bn |
| 10 | Akebia Therapeutics | 249.25 Mn | 93.70 Mn | 38.70 Mn | 1.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.51 Mn |
| Jun 30, 2026 | 1.51 Mn |
| Mar 31, 2026 | 956,000.00 |
| Mar 31, 2026 | 956,000.00 |
| Dec 31, 2025 | 1.22 Mn |
| Dec 31, 2025 | 1.22 Mn |
| Sep 30, 2025 | 1.47 Mn |
| Sep 30, 2025 | 1.47 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Mar 31, 2025 | 1.90 Mn |
| Mar 31, 2025 | 1.90 Mn |
| Dec 31, 2024 | 2.20 Mn |
| Dec 31, 2024 | 2.20 Mn |
| Sep 30, 2024 | 2.53 Mn |
| Sep 30, 2024 | 2.53 Mn |
| Jun 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 2.90 Mn |
| Mar 31, 2024 | 3.27 Mn |
| Mar 31, 2024 | 3.27 Mn |